콧구멍 폴립증 치료 시장 : 규모 조사, 치료 유형별, 최종 사용자별, 지역별 예측(2022-2032년)

The global Nasal Polyposis Treatment Market is valued approximately at USD 4.6 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.3% over the forecast period 2024-2032. Nasal polyposis treatment typically involves a combination of medications and surgery, including corticosteroids and endoscopic sinus surgery. This dual approach aims to alleviate symptoms, reduce inflammation, and prevent recurrence. With continuous advancements in therapeutic options and a rising prevalence of chronic rhinosinusitis with nasal polyps, the market is poised for substantial growth. The market's trajectory is further bolstered by the development of new pharmacological treatments aimed at minimizing side effects and improving patient outcomes.

The global nasal polyposis treatment market is experiencing robust growth, driven by the launch of innovative products by key industry players and the expanding availability of these treatments through retail pharmacies. Companies are focused on refining existing treatment modalities to enhance patient relief and minimize side effects, such as cough and swelling. Additionally, research into new drug formulations is underway, targeting the mitigation of adverse reactions associated with current therapies. The surge in chronic rhinosinusitis cases, especially among the elderly, is a significant growth driver, coupled with advancements in surgical technologies and increased R&D activities.

The regional landscape of the nasal polyposis treatment market highlights North America as a dominant player, holding a 41.5% market share and expected to grow at a CAGR of 6.1% from 2023 to 2033. This growth is attributed to a higher incidence of respiratory and allergic disorders, as well as robust research activities and regulatory approvals in the United States. Meanwhile, the Asia Pacific region is poised for the fastest growth during the forecast period, propelled by a high prevalence of allergic disorders and strong pharmaceutical industry growth. Notably, China's significant population and proactive healthcare initiatives contribute to the region's market expansion.

Major market players included in this report are:

• Sanofi S.A
• Merck & Co. Inc.
• OptiNose USA Inc.
• Intersect ENT Inc.
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• GSK plc.
• F. Hoffmann- La Roche Ltd.
• Teva Pharmaceutical Industries Inc.
• Novartis AG

The detailed segments and sub-segment of the market are explained below:

By Type of Treatment:

• Pharmacological Therapies
• Surgeries

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Nasal Polyposis Treatment Market Executive Summary

• 1.1. Global Nasal Polyposis Treatment Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Type of Treatment
  • 1.3.2. By End User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Nasal Polyposis Treatment Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Nasal Polyposis Treatment Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Increasing Prevalence of Chronic Rhinosinusitis
  • 3.1.2. Technological Advancements in Treatment
  • 3.1.3. Growing Elderly Population
• 3.2. Market Challenges
  • 3.2.1. High Cost of Treatment
  • 3.2.2. Dearth of Skilled Healthcare Professionals
• 3.3. Market Opportunities
  • 3.3.1. Development of Novel Therapeutic Treatments
  • 3.3.2. Expanding Retail Pharmacy Networks
  • 3.3.3. Government Healthcare Initiatives

Chapter 4. Global Nasal Polyposis Treatment Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top Investment Opportunities
• 4.4. Top Winning Strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Nasal Polyposis Treatment Market Size & Forecasts by Type of Treatment 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Nasal Polyposis Treatment Market: Type of Treatment Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Pharmacological Therapies
  • 5.2.2. Surgeries

Chapter 6. Global Nasal Polyposis Treatment Market Size & Forecasts by End User 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Nasal Polyposis Treatment Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Hospitals
  • 6.2.2. Ambulatory Surgical Centers
  • 6.2.3. Specialty Clinics

Chapter 7. Global Nasal Polyposis Treatment Market Size & Forecasts by Region 2022-2032

• 7.1. North America Nasal Polyposis Treatment Market
  • 7.1.1. U.S. Nasal Polyposis Treatment Market
    • 7.1.1.1. Type of Treatment breakdown size & forecasts, 2022-2032
    • 7.1.1.2. End User breakdown size & forecasts, 2022-2032
  • 7.1.2. Canada Nasal Polyposis Treatment Market
• 7.2. Europe Nasal Polyposis Treatment Market
  • 7.2.1. U.K. Nasal Polyposis Treatment Market
  • 7.2.2. Germany Nasal Polyposis Treatment Market
  • 7.2.3. France Nasal Polyposis Treatment Market
  • 7.2.4. Spain Nasal Polyposis Treatment Market
  • 7.2.5. Italy Nasal Polyposis Treatment Market
  • 7.2.6. Rest of Europe Nasal Polyposis Treatment Market
• 7.3. Asia-Pacific Nasal Polyposis Treatment Market
  • 7.3.1. China Nasal Polyposis Treatment Market
  • 7.3.2. India Nasal Polyposis Treatment Market
  • 7.3.3. Japan Nasal Polyposis Treatment Market
  • 7.3.4. Australia Nasal Polyposis Treatment Market
  • 7.3.5. South Korea Nasal Polyposis Treatment Market
  • 7.3.6. Rest of Asia Pacific Nasal Polyposis Treatment Market
• 7.4. Latin America Nasal Polyposis Treatment Market
  • 7.4.1. Brazil Nasal Polyposis Treatment Market
  • 7.4.2. Mexico Nasal Polyposis Treatment Market
  • 7.4.3. Rest of Latin America Nasal Polyposis Treatment Market
• 7.5. Middle East & Africa Nasal Polyposis Treatment Market
  • 7.5.1. Saudi Arabia Nasal Polyposis Treatment Market
  • 7.5.2. South Africa Nasal Polyposis Treatment Market
  • 7.5.3. Rest of Middle East & Africa Nasal Polyposis Treatment Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Sanofi S.A
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Market Strategies
  • 8.3.2. Merck & Co. Inc.
  • 8.3.3. OptiNose USA Inc.
  • 8.3.4. Intersect ENT Inc.
  • 8.3.5. Pfizer Inc.
  • 8.3.6. Regeneron Pharmaceuticals Inc.
  • 8.3.7. GSK plc.
  • 8.3.8. F. Hoffmann- La Roche Ltd.
  • 8.3.9. Teva Pharmaceutical Industries Inc.
  • 8.3.10. Novartis AG

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes